Venture - Series Unknown Oncology Companies

Haemalogix focuses on the development and commercialization of novel immuno-oncology and immune-therapies.

Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

Wanda Health provides applications and machine learning based health informatics for remote health and patient management.

Axiom Therapeutics is a health tech company that provides computational drug discovery solutions for untreatable cancers.

Specializes in the development of nanoparticles for cancer treatment.

Saccharo is a biotech start-up in the immuno-oncology space that develops products for the treatment of cancer and other novel diseases.

Apmonia Therapeutics is a biotech company that develop therapeutic strategies towards multiple types of cancer.

Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering.

Spot BioSystems is a bioengineering firm that specializes in extracellular vesicle mediated mRNA therapy

Elucida Oncology develops targeted C'Dot Drug Conjugates (CDCs) for patients with primary solid tumor and metastatic cancer.

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.

iCellate is a Swedish research and development company focused on cancer research and detection products.

Salish Bioscience is an oncology diagnostics company that develops advanced liquid biopsies.

ZapIT provides a quality assurance practice management system for medical imaging and radiation oncology and related documentation needs.

NeoSoma is a neuro-oncology AI platform providing AI imaging solutions for precise medical management.

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

Continuous Care Management

Avenda Health brings superhuman abilities to cancer surgeons and oncologists using AI

Resolute is advancing a first-in-class platform of cytotoxics and radiotherapeutics for aggressive and hard to treat solid tumors.

CancerNavigator offers cancer navigation and analytics, connecting patients with care experts and providing personalized support.

A medical device company changing the cancer treatment balance in survivorship and quality of life: improving both

Precision oncology company developing the next generation of biomarkers to advance cancer diagnostics with multimodal AI Platform Polaris‚Ñ¢.

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.